Orchid Pharma Limited chart

Last update: 2022-06-03
Key statistics and financials
Revenue per share 137.65
Dividend & YieldN/A₹ (N/A)
Beta N/A
Market capitalization 12.27B
Operating cash flow 889.52M
ESG Scores unknown

Company description

Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of bulk actives, formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins, veterinary products, and non-antibiotics. The company also provides anti-infectives, anti-inflammatory, central nervous system, cardiovascular segment, nutraceuticals, and other oral and sterile products, as well as offers new drug discovery systems and pharmaceutical research and development services. It also exports its products to approximately 40 countries internationally. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai, India. Orchid Pharma Limited is a subsidiary of Dhanuka Laboratories Limited.

Sector: Healthcare - Industry: Drug Manufacturers—Specialty & Generic

Financial Ratios
Quick Ratio1.15
Working Capital-0.01
Return On Equity-0
Debt To Equity0.32
Fixed Asset Ratio0
Fixed Interest Cover-0.89

Financial data

Financial Statements

Cashflow Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Change To Liabilities -576.76M 76.92M 179.31M 473.63M
Total Cashflows From Investing Activities 454.73M 1.67B 672.05M 1.16B
Net Borrowings -2.9B -2.9B -1.25B -1.85B
Total Cash From Financing Activities -3M -2.5B -1.65B -2.17B
Change To Operating Activities -675.83M -38.81M 606.33M 325.86M
Issuance Of Stock 400M 400M
Net Income 694.08M -1.31B -1.17B -19.51M
Change In Cash 571.98M -24.19M -741.98M -113.87M
Effect Of Exchange Rate
Total Cash From Operating Activities 120.24M 808.03M 235.86M 889.52M
Depreciation 1.28B 1.18B 1.09B 870.25M
Change To Account Receivables -91.5M 440.11M -820.25M -229.19M
Other Cashflows From Financing Activities -3M -3.25M -399.09M -320.12M
Change To Netincome -768.84M 320.6M 681.59M -556.87M
Capital Expenditures -66.27M -42.42M -6.04M -144.03M

Income Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Research Development
Income Before Tax 694.08M -696.92M -952.49M -604.21M
Net Income 694.08M -1.31B -1.17B -19.51M
Selling General Administrative 944.94M 863.42M 686.14M 632.77M
Gross Profit 3.07B 2.6B 2.09B 2.46B
Ebit -800.45M -721.75M -505.74M -284.1M
Operating Income -800.45M -721.75M -505.74M -284.1M
Interest Expense -3M -41.59M -513.36M -320.12M
Income Tax Expense
Total Revenue 6B 4.84B 4.5B 5.6B
Cost Of Revenue 2.93B 2.24B 2.41B 3.14B
Total Other Income ExpenseNet 1.49B 24.83M -446.75M -320.12M
Net Income From Continuing Ops 694.08M -696.92M -952.49M -604.21M
Net Income Applicable To Common Shares 694.08M -1.31B -1.17B -19.51M

Balance Sheet Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Total Liabilities 37.81B 6.94B 5.84B 4.63B
Total Stockholder Equity -7.04B 7.66B 6.53B 6.47B
Other Current Liabilities 130.44M 14.67M 25.64M 103M
Total Assets 30.77B 14.6B 12.37B 11.11B
Common Stock 889.64M 408.16M 408.16M 408.16M
Other Current Assets 1.41B 2.57B 2.27B 985.97M
Retained Earnings -13.11B -13.56B -14.72B
Treasury Stock 538.41M 16.16B 16.19B 6.07B
Cash 923.11M 898.91M 156.94M 80.63M
Total Current Liabilities 23.46B 1.75B 1.42B 2.41B
Other Stockholder Equity 538.41M 16.16B 16.19B 6.07B
Property, Plant, and Equipment 14.04B 8.59B 6.78B 5.93B
Total Current Assets 7.67B 5.69B 5.5B 4.5B
Net Tangible Assets -8.34B 7.41B 6.53B 6.47B
Net Receivables 1.22B 679.78M 1.36B 1.71B
Accounts Payable 3.02B 1.02B 1.1B 1.68B


Insider Transactions

Here are the insider transactions of stock shares related to Orchid Pharma Limited:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Dhanuka Laboratories LtdOther at price 6.58 per share.D2021-06-25Promoter3.28M
Rao (Raghavendra K)D2017-01-30Managing Director200k
Raghavendra (Vijayalakshmi)D2017-01-25Promoter100k
Divya (R)D2016-10-28Promoter2.05M
Sowmya (R)D2016-10-28Promoter550k
Sowmya (R)D2016-10-28Promoter1.1M
Rao (Raghavendra K)D2016-10-25Managing Director130k
Orchid Health Care Pvt LtdD2016-10-19Promoter200k
Rao (Raghavendra K)D2016-10-19Managing Director800k
Rao (Raghavendra K)D2016-10-14Managing Director531k
Orchid Health Care Pvt LtdD2016-10-05Promoter962.69k
Orchid Health Care Pvt LtdD2016-10-04Promoter3.69M
Rao (Raghavendra K)D2016-10-04Managing Director581.12k
Rao (Raghavendra K)D2016-10-03Managing Director525k
Rao (Raghavendra K)D2016-09-30Managing Director300k
Rao (Raghavendra K)D2016-09-27Managing Director163.66k
Rao (Raghavendra K)D2016-09-21Managing Director48.36k
Rao (Raghavendra K)D2016-09-20Managing Director40k
Rao (Raghavendra K)D2016-09-16Managing Director59.5k
Rao (Raghavendra K)D2016-09-15Managing Director215.04k
Rao (Raghavendra K)D2016-09-14Managing Director625k
Rao (Raghavendra K)D2016-09-09Managing Director102.5k
Rao (Raghavendra K)D2016-09-08Managing Director27k
Rao (Raghavendra K)D2016-09-07Managing Director16.24k
Rao (Raghavendra K)D2016-09-01Managing Director25k
Rao (Raghavendra K)D2016-08-24Managing Director15k
Rao (Raghavendra K)D2016-08-24Managing Director20k
Rao (Raghavendra K)D2016-08-23Managing Director11.08k
Rao (Raghavendra K)D2016-08-22Managing Director50k
Rao (Raghavendra K)D2016-08-19Managing Director20k
Rao (Raghavendra K)D2016-08-18Managing Director70.1k
Rao (Raghavendra K)D2016-07-22Managing Director50k
Rao (Raghavendra K)D2016-07-21Managing Director50k
Rao (Raghavendra K)D2016-07-20Managing Director10k
Rao (Raghavendra K)D2016-07-19Managing Director20k
Rao (Raghavendra K)D2016-07-01Managing Director5k
Rao (Raghavendra K)D2016-06-30Managing Director5k
Rao (Raghavendra K)D2016-06-29Managing Director7.5k
Rao (Raghavendra K)D2016-06-24Managing Director20k
Rao (Raghavendra K)D2016-06-22Managing Director1.91k
Rao (Raghavendra K)D2016-06-21Managing Director20k
Sowmya (R)D2016-06-20UNREPORTED5k
Rao (Raghavendra K)D2016-06-17Managing Director15k
Sowmya (R)D2016-06-16UNREPORTED100k
Sowmya (R)D2016-06-15UNREPORTED20k
Sowmya (R)D2016-06-14UNREPORTED10k
Sowmya (R)D2016-06-13UNREPORTED3k
Sowmya (R)D2016-06-10UNREPORTED5k
Sowmya (R)D2016-06-09UNREPORTED12k
Sowmya (R)D2016-06-08UNREPORTED20k
Sowmya (R)D2016-06-07UNREPORTED30k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Orchid Pharma Limited. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Orchid Pharma Limited

Here is the result of two systematic investment strategies applied to Orchid Pharma Limited. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Orchid Pharma Limited

The following chart shows the equity curve of the two systematic investment strategies applied to Orchid Pharma Limited:

Orchid Pharma Limited automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 9.92% on the backtest period.

Performance at glance

Performance

9.92 %

Latent gain

28.0 ₹

Invested capital

282.3 ₹

Annualized return

27.56 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Orchid Pharma Limited

This is the result of two momentum investment strategies applied to Orchid Pharma Limited. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Orchid Pharma Limited

The following chart shows all the entries opened by the momentum investment system on Orchid Pharma Limited:

Orchid Pharma Limited momentum entries
  • The first momentum investment strategy would give -25.83% of return on Orchid Pharma Limited. That represents -108.05₹ of latent gain with 418.35₹ of employed capital.
  • The second momentum investment strategy would give 0% of return on Orchid Pharma Limited. That represents 0.0₹ of latent gain with 0.0₹ of employed capital.
Performance at glance (1Q Momentum)

Performance

-25.83 %

Latent gain

-108.05 ₹

Invested capital

418.35 ₹

Annualized return

-0.0 %
Performance at glance (2Q Momentum)

Performance

0 %

Latent gain

0.0 ₹

Invested capital

0.0 ₹

Annualized return

-0.0 %

Momentum equity curve on Orchid Pharma Limited

The following chart shows the equity curve of the two momentum strategies applied to Orchid Pharma Limited:

Orchid Pharma Limited momentum equity

Note: the dividends potentially given by Orchid Pharma Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Orchid Pharma Limited

The following chart shows the employed capital evolution of the two momentum strategies on Orchid Pharma Limited since the beginning:

Orchid Pharma Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250₹, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000₹.


Buy the dip strategy result on Orchid Pharma Limited

Buy the dip entry openings on Orchid Pharma Limited

Orchid Pharma Limited

The performance achieved by the robo-advisor on Orchid Pharma Limited is 0%. That represents 0.0$ of latent gain with 0.0₹ of employed capital. The following chart shows Orchid Pharma Limited stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Orchid Pharma Limited, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 ₹

Invested capital

0.0 ₹

Annualized return

-0.0 %

Equity curve of the strategy applied to Orchid Pharma Limited

The following chart shows the result of the investment strategy applied to Orchid Pharma Limited:

Orchid Pharma Limited

Note: the dividends potentially given by Orchid Pharma Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Orchid Pharma Limited

The following chart shows the employed capital evolution since the beginning of the investment strategy on Orchid Pharma Limited:

Orchid Pharma Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Orchid Pharma Limited

In this section, I will compare the three previous investment strategies applied to Orchid Pharma Limited.

Equity curve comparison on Orchid Pharma Limited

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Orchid Pharma Limited investment strategy comparison

Employed capital comparison on Orchid Pharma Limited

Orchid Pharma Limited investment comparison

Performance comparison on Orchid Pharma Limited

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 9.92% 28.0₹ 282.3₹ 27.56%
Momentum 1 quarter -25.83% -108.05₹ 418.35₹ -215.25%
Momentum 2 quarters 0% 0.0₹ 0.0₹ -0.0%
Non-directional 0% 0.0₹ 0.0₹ -0.0%
Annualized return comparison

Automatic investment

27.56 %

Momentum 1Q

-0.0 %

Momentum 2Q

-0.0 %

Non-directional

-0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Orchid Pharma Limited:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Orchid Pharma Limited and the other stocks. There may be false positives or some missing correlated stocks. If the price of Orchid Pharma Limited does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Orchid Pharma Limited
Country India
City Chennai
Address Orchid Towers
Phone 91 44 2821 1000
Website www.orchidpharma.com
FullTime employees
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
Exchange XNSE
Ticker ORCHPHARMA.XNSE
Market

Orchid Pharma Limited ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 0
Peer Environment Performance unknown
Environment Percentile unknown
Palm Oil unknown
Nuclear unknown
Fur Leather unknown
GMO unknown
Coal unknown
Pesticides unknown
Animal Testing unknown

Social scores

Social ESG Factors Scores
Social Score 0
Peer Social Performance unknown
Social Percentile unknown
Highest Controversy unknown
Peer Highest Controversy Performance unknown
Adult unknown
Gambling unknown
Alcoholic unknown
Tobacco unknown
Catholic unknown
Controversial Weapons unknown
Small Arms unknown
Military Contract unknown
Peer Count unknown

Related Controversy:


Governance scores

Governance ESG Factors Scores
Governance Score 0
Peer Governance Performance unknown
Governance Percentile unknown

ESG at glance
Total ESG Scores: unknown
Environment Score: 0
Social Score: 0
Governance Score: 0

ESG Performance: unknown

Peer Group: unknown

Peer Esg Score Performance: unknown

Rating Year: unknown

Rating Month: unknown

Max Age: unknown

Percentile: unknown